Chonglei Bi
Publications by Year
Research Areas
Cancer Mechanisms and Therapy, Melanoma and MAPK Pathways, Acute Myeloid Leukemia Research, Synthesis and biological activity, Multiple Myeloma Research and Treatments
Most-Cited Works
- → The histone methyltransferase inhibitor, DZNep, up-regulates TXNIP, increases ROS production, and targets leukemia cells in AML(2011)212 cited
- → EZH2 overexpression in natural killer/T-cell lymphoma confers growth advantage independently of histone methyltransferase activity(2013)164 cited
- → Enhanced activation of STAT pathways and overexpression of survivin confer resistance to FLT3 inhibitors and could be therapeutic targets in AML(2009)161 cited
- → EZH2 phosphorylation by JAK3 mediates a switch to noncanonical function in natural killer/T-cell lymphoma(2016)137 cited
- → Dysregulated microRNAs affect pathways and targets of biologic relevance in nasal-type natural killer/T-cell lymphoma(2011)115 cited
- → Inhibition of LIN28B impairs leukemia cell growth and metabolism in acute myeloid leukemia(2017)75 cited
- → PRL-3, a Metastasis Associated Tyrosine Phosphatase, Is Involved in FLT3-ITD Signaling and Implicated in Anti-AML Therapy(2011)65 cited
- → MicroRNA: Important Player in the Pathobiology of Multiple Myeloma(2014)51 cited
- → MEK Inhibition Overcomes Cisplatin Resistance Conferred by SOS/MAPK Pathway Activation in Squamous Cell Carcinoma(2015)51 cited
- → Genome-wide pharmacologic unmasking identifies tumor suppressive microRNAs in multiple myeloma(2015)51 cited